INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 March 2016
Net Assets |
£186m |
Net Assets per share |
480p |
Share price |
411p |
Total value of unquoted investments |
£21m |
Total number of portfolio companies |
88 |
Top Ten Holdings
Company Name |
% NAV |
Amgen |
8.1 |
Celgene |
8.0 |
Gilead |
8.0 |
Biogen |
6.7 |
Medivation |
5.8 |
Regeneron |
4.8 |
Alexion |
4.6 |
Ophthotech |
3.0 |
Incyte |
3.0 |
Genmab |
2.6 |
|
----------- |
Total |
54.6 |
Portfolio Revenue Split |
% NAV |
Revenue Generating |
79 |
Near Revenue |
2 |
No sales in the near term |
19 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
84 |
Europe & UK |
16 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
89 |
Unquoted |
11 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
27 APRIL 2016